Intent to Sole Source- Automated Blood Bank Instrumentation
Inactive on SAM.gov — responses were due 22 Sep 2026 · No Set aside used · Department of the Air Force, DoD · Wright Patterson AFB, OH · NAICS 325413 · Solicitation PZIBABPA
Following NAICS 325413? Get new solicitations in it by email as they post — no account needed.
SAM.gov marked this notice inactive — responses were due 22 September 2026.
No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.
Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.
This one has closed. We'll email you when new NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.
Description
INTENT TO SOLE SOURCE The Air Force Life Cycle Management Center (AFLCMC/PZIBA) intends to award a sole-source, firm-fixed-price Blanket Purchase Agreement (BPA) to QuidelOrtho Sales Company, LLC, located at 9975 Summers Ridge Road, San Diego, California, 92121. This proposed action is for automated blood bank instrumentation, reagents, consumables, and associated support for the 88th Medical Group Laboratory Flight at Wright-Patterson Air Force Base (WPAFB). This requirement is for a fully automated, continuous-access blood bank system integrated with current and future laboratory information systems, including MHS Genesis, together with the associated training, maintenance, repair, and reagent support necessary to maintain uninterrupted blood bank operations. Extensive market research was conducted to identify potential sources. Techniques included, but were not limited to, internet market research, review of similar procurements, input from Subject Matter Experts (SMEs), review of the Government s minimum technical requirements, and a Sources Sought notice. The BPA justification states that no existing mandatory source has been identified that can satisfy the organization s specific blood and blood product requirements. The WPAFB 88th Medical Group requires a blood bank instrumentation solution that meets the minimum technical requirements established in the Statement of Work (SOW). These requirements include a fully automated blood bank system using the required methodology, support for required blood bank testing on a single platform, integration capability with MHS Genesis, FDA-approved reagent kits, and instrument-specific reagents, controls, standards, and hardware from the manufacturer producing the instrument. Utilizing a system that does not meet these requirements would not satisfy the Government s operational and patient care needs. As part of this market research effort, a Sources Sought notice was posted on SAM.gov on 20 August 2026. One response was received. The 88th Medical Group completed a technical evaluation and found the submission technically unacceptable. The evaluations identified deficiencies including wrong methodology and instrumentation, different reagents for the instrumentation, and failure to meet upgrade-of-equipment requirements. The Contracting Officer has determined that only one source is reasonably available: QuidelOrtho Sales Company, LLC. This proposed procurement will be a Sole Source under North American Industry Classification System code (NAICS) 325413 Blood derivative in-vitro diagnostic substances manufacturing, with a size standard of 1,250 employees. The proposed source is QuidelOrtho Sales Company, LLC., 9975 Summers Ridge Road, San Diego, California, 92121. Submission Instructions and Points of Contact: This notice of intent is not a request for competitive quotations. However, interested parties who believe they can satisfy the requirements must provide a capability statement with clear and convincing evidence of their ability to do so. The statement must demonstrate the vendor's capability to provide automated blood bank instrumentation, reagents, consumables, and support services that are fully compatible with the Government s minimum technical and operational requirements identified in the Statement of Work. A simple statement of capability is not sufficient. All responses, questions, and capability statements shall be submitted via email to the following points of contact no later than 22 September 2026 at 3:00PM EST. Contract Specialist: Alejandro Quiles, alejandro.quiles_sanchez.1@us.af.mil Contracting Officer: Claire Hess, claire.hess@us.af.mil All correspondence sent via email must contain the subject line: "Intent to Sole Source- Automated Blood Bank Instrumentation & Support." Be advised that emails without this exact subject line or with prohibited attachments (.zip, .exe) may be blocked by network filters. This notice is not a request for competitive proposals or quotes. A decision by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Attachments: Statement of Work Justification and Approval Document_ Redacted
FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.
Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.
